| JYHB2500088 | 美法仑片 | melphalan | Tablet | Chemical Drugs | Supplementary Application | 2025-02-25 | | Excella GmbH;Aspen Pharmacare Australia Pty Ltd | | | view |
| JYHB1800406 | 美法仑片 | melphalan | Tablet | Chemical Drugs | Supplementary Application | 2018-06-28 | 凯顺富达（北京）生物科技有限公司 | Kaishun Fuda (Beijing) Biotechnology Co Ltd;Excella GmbH;Aspen Pharmacare Australia Pty Ltd | Certificate Issued | 2018-08-21 | view |
| JYHZ2200314 | 美法仑片 | melphalan | Tablet | Chemical Drugs | License Renew | 2022-11-18 | | Aspen Pharmacare Australia Pty Ltd;Excella GmbH | | | view |
| J0301149 | 美法仑片 | melphalan | Tablet | Chemical Drugs | Supplementary Application | 2003-08-13 | GlaxoSmithKline Australia Pty Ltd | Glaxo Smithkline Australia Pty Ltd;GlaxoSmithKline (China) Investment Co Ltd | Certificate Issued | 2004-03-10 | view |
| JTH2300036 | 美法仑片 | melphalan | Tablet | Chemical Drugs | Disposable Import Drug Application | 2023-02-11 | | Excella GmbH;Aspen Pharmacare Australia Pty Ltd;Aspen China Company Limited (Guangzhou) | | | view |
| JYHL2000001 | 美法仑片 | melphalan | Tablet | Chemical Drugs(5.2) | Import Drug Application | 2020-09-29 | 浙江医学科技开发有限公司 | Zhejiang Medical Technology Development Co Ltd;Alvogen Malta Operations Ltd | In Review | 2020-09-28 | view |
| JYHZ1400446 | 美法仑片 | melphalan | Tablet | Chemical Drugs | License Renew | 2014-07-16 | | Aspen Pharmacare Australia Pty Ltd;Excella GmbH | Certificate Issued | 2018-01-04 | view |
| JYHS2101032 | 美法仑片 | melphalan | Tablet | Chemical Drugs(5.2) | Import Drug Application | 2021-08-25 | | Alvogen Inc;Lotus Pharmaceutical (Shanghai) Health Management Consulting Ltd;EirGen Pharma Ltd | | | view |
| JYHB1800147 | 美法仑片 | melphalan | Tablet | Chemical Drugs | Supplementary Application | 2018-02-09 | 凯顺富达（北京）生物科技有限公司 | Kaishun Fuda (Beijing) Biotechnology Co Ltd;Aspen Pharmacare Australia Pty Ltd;Excella GmbH | Filed | 2018-02-26 | view |
| B20010131 | 美法仑片 | melphalan | Tablet | Chemical Drugs | Import Drug Application | 2001-09-28 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd | Approval Completed-Pending Certificated | 2002-08-07 | view |
| JYHB2200588 | 美法仑片 | melphalan | Tablet | Chemical Drugs | Supplementary Application | 2022-11-01 | | Aspen Pharmacare Australia Pty Ltd;Excella GmbH | | | view |
| CYHL0500032 | 美法仑片 | melphalan | Tablet | Chemical Drugs(6) | Generic Drug | 2006-01-09 | 重庆莱美药业有限公司 | Chongqing Lummy Pharmaceutical Co Ltd | Certificate Issued | 2008-05-21 | view |
| JYHB2000514 | 美法仑片 | melphalan | Tablet | Chemical Drugs | Supplementary Application | 2020-04-26 | 凯顺富达（北京）生物科技有限公司 | Kaishun Fuda (Beijing) Biotechnology Co Ltd;Excella GmbH;Aspen Pharmacare Australia Pty Ltd | Filed | 2020-05-06 | view |
| J0301828 | 美法仑片 | melphalan | Tablet | Chemical Drugs | License Renew | 2003-12-17 | Glaxo SmithKline Australia Pty Ltd | Glaxo Smithkline Australia Pty Ltd;GlaxoSmithKline (China) Investment Co Ltd | Approval Completed-Pending Certificated | 2004-06-09 | view |
| CXHL0600264 | 美法仑 | melphalan | Active ingredient | Chemical Drugs(3.1) | New Drug Application | 2006-06-27 | 山东蓝金生物工程有限公司 | Shandong LanJin Bioengineering Co Ltd | Certificate Issued | 2009-06-08 | view |
| CXHS0502834 | 美法仑 | melphalan | Active ingredient | Chemical Drugs(3.1) | New Drug Application | 2006-01-19 | 重庆莱美药业有限公司 | Chongqing Lummy Pharmaceutical Co Ltd | Certificate Issued | 2008-06-20 | view |
| CYHS1700221 | 美法仑 | melphalan | Active ingredient | Chemical Drugs(3) | Generic Drug | 2017-12-12 | 西安力邦制药有限公司 | Xi'an Libang Pharmaceutical Co Ltd | In Review | 2017-12-11 | view |
| CXHL0600265 | 注射用美法仑 | melphalan | Lyophilized | Chemical Drugs(3.1) | New Drug Application | 2006-06-27 | 山东蓝金生物工程有限公司 | Shandong LanJin Bioengineering Co Ltd | Certificate Issued | 2009-02-12 | view |
| CYHS1700220 | 注射用美法仑 | melphalan | Lyophilized | Chemical Drugs(3) | Generic Drug | 2017-12-06 | 西安力邦制药有限公司 | Xi'an Libang Pharmaceutical Co Ltd | In Review | 2017-12-04 | view |
| JYHZ2400223 | 注射用盐酸美法仑 | MELPHALAN HYDROCHLORIDE | Lyophilized | Chemical Drugs(5.1) | License Renew | 2024-08-13 | | Baxter Oncology GmbH;Acrotech Biopharma Inc;CASI(Beijing)Pharmaceuticals Technology Co Ltd | | | view |
